Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore

HKEX:3320 stock price forecast

How will HKEX:3320 stock perform in 2026 and 2030?

This page primarily displays the projected price range for HKEX:3320 stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of HKEX:3320, the development trends of China Resources Pharmaceutical Group Ltd., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for HKEX:3320. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines China Resources Pharmaceutical Group Ltd.'s financial performance and industry trends to provide short-term price predictions for HKEX:3320 stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year HKEX:3320 stock price forecast

Price target:
5.22 HKD
+13.73%
Based on 1-year price forecasts from 69 analysts, the highest estimate is 6.36 HKD, while the lowest estimate is 3.34 HKD.

Analyst rating for HKEX:3320

Based on ratings from 76 analysts over the past three months, the overall consensus is Strong buy.

Strong buy
2
Buy
60
Hold
1
Sell
12
Strong sell
1

FAQ

How has HKEX:3320's EPS performed recently?

HKEX:3320's EPS is projected to reach -- HKD next quarter. Explore more China Resources Pharmaceutical Group Ltd. financial data and stay up to date on the company's latest developments on the HKEX:3320 stock details page.

What is the revenue forecast for HKEX:3320 next quarter?

China Resources Pharmaceutical Group Ltd.'s revenue is projected to reach -- HKD in the next quarter. You can view China Resources Pharmaceutical Group Ltd.'s revenue and earnings on the HKEX:3320 stock details page.

What is the price target for HKEX:3320?

Based on analyst estimates, the most likely target price for HKEX:3320 over the next 12 months is 5.22 HKD, with a projected high of 6.36 HKD and a projected low of 3.34 HKD. To track whether this target is reached within the next year, you can view the HKEX:3320 stock price chart on the HKEX:3320 stock details page to check the current HKEX:3320 stock price, or follow the latest developments related to HKEX:3320 on the HKEX:3320 Stock News page.

What is the analyst rating for HKEX:3320?

We collected ratings from 76 analysts who have evaluated HKEX:3320 stock over the past three months. Most analysts maintain a Strong buy outlook, and after aggregating all opinions, the overall consensus rating is Strong buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of HKEX:3320 stock in 2030?

Based on price forecasts and analyses of China Resources Pharmaceutical Group Ltd. from Wall Street analysts and major investment banks, HKEX:3320 is projected to trade between 9.18 HKD and 45.90 HKD in 2030.

HKEX:3320 stock price change

Sa huling araw ng trading, HKEX:3320 sarado ang stock sa 4.59 HKD, na may pagbabago sa presyo ng -0.43% para sa araw.

Trade stock futuresHKEX:3320 stock details

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more
HKEX/
HKEX:3320 stock price forecast